While research into GLP-1 medications and breast cancer is in its early stages, there are indications that these drugs could be an important tool in reducing the risk of breast cancer recurrence in overweight and obese patients and thrivers
A (Neetu Ahluwalia, M.D.) is a respected physician with extensive experience in preventative care, metabolic health, and integrative medicine
Other forms may not be properly absorbed by the body, resulting in reduced effectiveness
Here's what's actually happening
Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alstrm Syndrome (AS) Patients With Moderate to Severe Obesity
Our service is certified, safe and effective